These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 29483603)

  • 1. Bumetanide for autism: more eye contact, less amygdala activation.
    Hadjikhani N; Åsberg Johnels J; Lassalle A; Zürcher NR; Hippolyte L; Gillberg C; Lemonnier E; Ben-Ari Y
    Sci Rep; 2018 Feb; 8(1):3602. PubMed ID: 29483603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving emotional face perception in autism with diuretic bumetanide: a proof-of-concept behavioral and functional brain imaging pilot study.
    Hadjikhani N; Zürcher NR; Rogier O; Ruest T; Hippolyte L; Ben-Ari Y; Lemonnier E
    Autism; 2015 Feb; 19(2):149-57. PubMed ID: 24343334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NKCC1 Chloride Importer Antagonists Attenuate Many Neurological and Psychiatric Disorders.
    Ben-Ari Y
    Trends Neurosci; 2017 Sep; 40(9):536-554. PubMed ID: 28818303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of bumetanide on neurodevelopmental impairments in patients with tuberous sclerosis complex: an open-label pilot study.
    van Andel DM; Sprengers JJ; Oranje B; Scheepers FE; Jansen FE; Bruining H
    Mol Autism; 2020 May; 11(1):30. PubMed ID: 32381101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomised controlled trial of bumetanide in the treatment of autism in children.
    Lemonnier E; Degrez C; Phelep M; Tyzio R; Josse F; Grandgeorge M; Hadjikhani N; Ben-Ari Y
    Transl Psychiatry; 2012 Dec; 2(12):e202. PubMed ID: 23233021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bumetanide to Treat Parkinson Disease: A Report of 4 Cases.
    Damier P; Hammond C; Ben-Ari Y
    Clin Neuropharmacol; 2016; 39(1):57-9. PubMed ID: 26757306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Pilot Study on the Combination of Applied Behavior Analysis and Bumetanide Treatment for Children with Autism.
    Du L; Shan L; Wang B; Li H; Xu Z; Staal WG; Jia F
    J Child Adolesc Psychopharmacol; 2015 Sep; 25(7):585-8. PubMed ID: 26258842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders.
    Lemonnier E; Villeneuve N; Sonie S; Serret S; Rosier A; Roue M; Brosset P; Viellard M; Bernoux D; Rondeau S; Thummler S; Ravel D; Ben-Ari Y
    Transl Psychiatry; 2017 Mar; 7(3):e1056. PubMed ID: 28291262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gaze-fixation, brain activation, and amygdala volume in unaffected siblings of individuals with autism.
    Dalton KM; Nacewicz BM; Alexander AL; Davidson RJ
    Biol Psychiatry; 2007 Feb; 61(4):512-20. PubMed ID: 17069771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological tools to target NKCC1 in brain disorders.
    Savardi A; Borgogno M; De Vivo M; Cancedda L
    Trends Pharmacol Sci; 2021 Dec; 42(12):1009-1034. PubMed ID: 34620512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amygdala volume and nonverbal social impairment in adolescent and adult males with autism.
    Nacewicz BM; Dalton KM; Johnstone T; Long MT; McAuliff EM; Oakes TR; Alexander AL; Davidson RJ
    Arch Gen Psychiatry; 2006 Dec; 63(12):1417-28. PubMed ID: 17146016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of the effect of bumetanide, a selective NKCC1 inhibitor, in patients with schizophrenia: A double-blind randomized trial.
    Rahmanzadeh R; Shahbazi A; Ardakani MK; Mehrabi S; Rahmanzade R; Joghataei MT
    Psychiatry Clin Neurosci; 2017 Jan; 71(1):72-73. PubMed ID: 27800670
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of bumetanide, a selective NKCC1 inhibitor, on hallucinations of schizophrenic patients; a double-blind randomized clinical trial.
    Rahmanzadeh R; Eftekhari S; Shahbazi A; Khodaei Ardakani MR; Rahmanzade R; Mehrabi S; Barati M; Joghataei MT
    Schizophr Res; 2017 Jun; 184():145-146. PubMed ID: 27956008
    [No Abstract]   [Full Text] [Related]  

  • 14. Look me in the eyes: constraining gaze in the eye-region provokes abnormally high subcortical activation in autism.
    Hadjikhani N; Åsberg Johnels J; Zürcher NR; Lassalle A; Guillon Q; Hippolyte L; Billstedt E; Ward N; Lemonnier E; Gillberg C
    Sci Rep; 2017 Jun; 7(1):3163. PubMed ID: 28600558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bumetanide enhances phenobarbital efficacy in a neonatal seizure model.
    Dzhala VI; Brumback AC; Staley KJ
    Ann Neurol; 2008 Feb; 63(2):222-35. PubMed ID: 17918265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired recognition of social emotions following amygdala damage.
    Adolphs R; Baron-Cohen S; Tranel D
    J Cogn Neurosci; 2002 Nov; 14(8):1264-74. PubMed ID: 12495531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bumetanide, a Diuretic That Can Help Children with Autism Spectrum Disorder.
    Shaker E; El Agami O; Salamah A
    CNS Neurol Disord Drug Targets; 2024; 23(4):536-542. PubMed ID: 37021422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel prodrug-based strategy to increase effects of bumetanide in epilepsy.
    Töllner K; Brandt C; Töpfer M; Brunhofer G; Erker T; Gabriel M; Feit PW; Lindfors J; Kaila K; Löscher W
    Ann Neurol; 2014 Apr; 75(4):550-62. PubMed ID: 24615913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consequences of inhibition of bumetanide metabolism in rodents on brain penetration and effects of bumetanide in chronic models of epilepsy.
    Töpfer M; Töllner K; Brandt C; Twele F; Bröer S; Löscher W
    Eur J Neurosci; 2014 Feb; 39(4):673-87. PubMed ID: 24251546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eye Gaze in Autism Spectrum Disorder: A Review of Neural Evidence for the Eye Avoidance Hypothesis.
    Stuart N; Whitehouse A; Palermo R; Bothe E; Badcock N
    J Autism Dev Disord; 2023 May; 53(5):1884-1905. PubMed ID: 35119604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.